Madrigal Pharmaceuticals, Inc. (MDGL) Social Stream
Madrigal Pharmaceuticals Inc (MDGL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MDGL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 11 | $203 | $145 | $174.5 | $99.42 | 75.52% |
| 2021-12-30 | 10 | $203 | $145 | $173.714 | $99.42 | 74.73% |
| 2022-02-25 | 9 | $203 | $131 | $167.571 | $99.42 | 68.55% |
The Trend in the Analyst Price Target
Over the past 14 months, MDGL's average price target has gone down $2.43.
Over the past 47 weeks, MDGL's average upside potential has been 92%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-07 | 15 | 220 | 111 | 178.550 | 90.95 | 96.32% |
| 2021-09-18 | 15 | 220 | 111 | 171.820 | 81.74 | 110.2% |
| 2021-11-07 | 11 | 203 | 145 | 174.500 | 93.04 | 87.55% |
| 2021-11-12 | 11 | 203 | 145 | 174.500 | 90.84 | 92.1% |
| 2022-02-25 | 10 | 203 | 131 | 167.571 | 93.53 | 79.16% |
MDGL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.44 | 8 | 0 | 0 | 1 | 1 | 9 |
The Trend in the Broker Recommendations
Over the past 22 months, MDGL's average broker recommendation rating improved by 0.27.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MDGL as an investment opportunity.
- In terms of how Madrigal Pharmaceuticals Inc fares relative to all US stocks, note that its average analyst price target is higher than 428.22% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Madrigal Pharmaceuticals Inc's number of analysts covering the stock is greater than 404.95% of them.
- In terms of how Madrigal Pharmaceuticals Inc fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 363.79% of that group.
- In the context of Pharmaceutical Products stocks, Madrigal Pharmaceuticals Inc's variance in analysts' estimates is lower than -53.75% of them.
In the Pharmaceutical Products industry, MCRB, LYEL, and LMDX are the three stocks most similar to Madrigal Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is MDGL a Buy, Hold or Sell? See the POWR Ratings now!